TSH Reflex T4 Testing Strategy

Rationale for TSH-First Strategy

The American College of Physicians recommends TSH as the most sensitive screening test for thyroid dysfunction, with sensitivity above 98% and specificity greater than 92% 1, 2

The Endocrine Society suggests ordering both tests upfront in cases of suspected central hypothyroidism due to pituitary or hypothalamic disease, where TSH may be inappropriately normal or low despite low free T4 3
The American Thyroid Association recommends ordering both tests in patients on immune checkpoint inhibitors, where hypophysitis can cause central hypothyroidism with low free T4 and low/normal TSH 3
The American Association of Clinical Endocrinologists advises monitoring patients already on levothyroxine therapy with both TSH and free T4 to distinguish adequate replacement from under- or overtreatment 2

The American College of Physicians recommends that when TSH is abnormal and triggers reflex free T4, TSH >10 mIU/L with normal free T4 indicates subclinical hypothyroidism requiring treatment regardless of symptoms 2
The American Thyroid Association suggests that TSH 4.5-10 mIU/L with normal free T4 indicates subclinical hypothyroidism, and recommends confirmatory testing in 3-6 weeks, as 30-60% normalize spontaneously 1, 2
The Endocrine Society recommends that TSH <0.1 mIU/L with elevated free T4 indicates overt hyperthyroidism requiring treatment 3
The American Association of Clinical Endocrinologists advises that TSH <0.1 mIU/L with normal free T4 indicates subclinical hyperthyroidism, and recommends considering T3 measurement to rule out T3 toxicosis 3

The American College of Physicians warns against ordering both tests routinely in primary care screening, as this wastes resources and reduces predictive value for true central hypothyroidism 1, 2
The American Thyroid Association recommends against using traditional TSH reference range (0.4-4.0 mIU/L) for reflex cutoffs, as this results in excessive free T4 testing without meaningful clinical benefit 1, 2
The Endocrine Society advises against failing to repeat abnormal TSH before initiating treatment, as transient elevations are common and 30-60% normalize on repeat testing 1, 2